SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28 days
| 7 |
54.9 |
% |
6.9 |
18.26 |
echocardiography |
0.0 |
|
0 |
|
|
99634 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
56 days
| 6 |
48.3 |
% |
8.1 |
19.84 |
echocardiography |
0.0 |
|
0 |
|
|
99636 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 10 |
47.3 |
% |
4.1 |
12.97 |
echocardiography |
0.0 |
|
0 |
|
|
99638 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 9 |
39.8 |
% |
2.5 |
7.5 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101719 |
2622 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
15.1 |
% |
1.0 |
4.47 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100349 |
2460 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 6 |
39.2 |
% |
5.8 |
14.21 |
echocardiography |
0.0 |
|
0 |
|
|
99809 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 8 |
32.62 |
% |
1.67 |
4.72 |
echocardiography |
0.0 |
|
0 |
|
|
101805 |
2641 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
30 |
15.8 |
% |
0.7 |
3.83 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100350 |
2460 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 12 |
38.55 |
% |
1.09 |
3.78 |
echocardiography |
0.0 |
|
0 |
|
|
101808 |
2641 |
WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
5 |
51.5 |
% |
1.7 |
3.8 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100303 |
2460 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 5 |
43.4 |
% |
1.5 |
3.35 |
echocardiography |
0.0 |
|
0 |
|
|
99640 |
2319 |
Crl:WI |
heart left ventricle fractional shortening |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 4 |
43.45 |
% |
1.78 |
3.56 |
echocardiography |
0.0 |
|
0 |
|
|
103119 |
2786 |
GK/CskCrljCrl |
heart left ventricle fractional shortening |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 4 |
38.2 |
% |
4.45 |
8.89 |
echocardiography |
0.0 |
|
0 |
|
|
103120 |
2786 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
41.0 |
% |
2.0 |
4.47 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
ledd/pw |
99363 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
48.0 |
% |
5.0 |
11.18 |
echocardiography |
0.0 |
ACF |
2 |
days |
ledd/pw |
99364 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
37.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99368 |
2278 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
44.3 |
% |
2.9 |
7.1 |
echocardiography |
0.0 |
|
0 |
|
|
99805 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 7 |
44.3 |
% |
2.8 |
7.41 |
echocardiography |
0.0 |
|
0 |
|
|
99806 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 10 |
35.33 |
% |
1.87 |
5.91 |
echocardiography |
0.0 |
|
0 |
|
|
101806 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
47.66 |
% |
2.43 |
8.76 |
echocardiography |
0.0 |
|
0 |
|
|
102007 |
2644 |
SD-Myh7bem1Blar+/- |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84 days
| 0 |
84.34 |
% |
11.12 |
|
echocardiography |
0.0 |
|
0 |
|
|
110947 |
3192 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
43.53 |
% |
1.18 |
4.25 |
echocardiography |
0.0 |
|
0 |
|
|
102008 |
2644 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 7 |
47.3 |
% |
4.1 |
10.85 |
echocardiography |
0.0 |
|
0 |
|
|
99804 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 7 |
41.6 |
% |
5.6 |
14.82 |
echocardiography |
0.0 |
|
0 |
|
|
99808 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 5 |
38.8 |
% |
2.6 |
5.81 |
echocardiography |
0.0 |
|
0 |
|
|
99642 |
2319 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
38.0 |
% |
2.0 |
5.29 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99367 |
2278 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 12 |
55.2 |
% |
1.9 |
6.58 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101720 |
2622 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 7 |
61.3 |
% |
2.7 |
7.14 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101722 |
2622 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175 days
| 10 |
34.0 |
% |
2.0 |
6.32 |
echocardiography |
0.0 |
ACF |
105 |
days |
|
99258 |
2278 |
SD-Myh7bem1Blar-/- |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84 days
| 0 |
81.02 |
% |
10.01 |
|
echocardiography |
0.0 |
|
0 |
|
|
110946 |
3192 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
47.0 |
% |
1.41 |
2.82 |
echocardiography |
0.0 |
|
0 |
|
|
99725 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
56 days
| 5 |
48.0 |
% |
3.9 |
8.72 |
echocardiography |
0.0 |
|
0 |
|
|
99635 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 5 |
46.8 |
% |
1.2 |
2.68 |
echocardiography |
0.0 |
|
0 |
|
|
99639 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
41.7 |
% |
2.62 |
5.24 |
echocardiography |
0.0 |
|
0 |
|
|
99724 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252 days
| 4 |
49.5 |
% |
2.2 |
4.4 |
echocardiography |
0.0 |
|
0 |
|
|
101655 |
2621 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
38.0 |
% |
4.0 |
11.31 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99255 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
38.0 |
% |
2.0 |
5.66 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99256 |
2278 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175 days
| 10 |
40.0 |
% |
1.0 |
3.16 |
echocardiography |
0.0 |
sham ACF |
105 |
days |
|
99257 |
2278 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 8 |
47.7 |
% |
1.9 |
5.37 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101721 |
2622 |
SD-Myh7bem1Blar+/+ |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84 days
| 0 |
72.52 |
% |
16.33 |
|
echocardiography |
0.0 |
|
0 |
|
SD-Myh7bem1Blar+/+ (RS:0005005) |
110945 |
3192 |
WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
12 |
41.1 |
% |
3.0 |
10.39 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100348 |
2460 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28 days
| 5 |
46.0 |
% |
8.4 |
18.78 |
echocardiography |
0.0 |
|
0 |
|
|
99633 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252 days
| 5 |
47.4 |
% |
2.4 |
5.37 |
echocardiography |
0.0 |
|
0 |
|
|
101656 |
2621 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
47.0 |
% |
2.1 |
5.14 |
echocardiography |
0.0 |
|
0 |
|
|
99637 |
2319 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
50.0 |
% |
3.0 |
6.71 |
echocardiography |
0.0 |
ACF |
2 |
days |
|
99366 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
39.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99369 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
43.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99370 |
2278 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 6 |
46.0 |
% |
8.3 |
20.33 |
echocardiography |
0.0 |
|
0 |
|
|
99807 |
2319 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
16.8 |
% |
1.6 |
6.4 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100304 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
18.0 |
% |
1.5 |
8.49 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100305 |
2460 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
44.28 |
% |
1.6 |
5.77 |
echocardiography |
0.0 |
|
0 |
|
|
102009 |
2644 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 7 |
44.43 |
% |
1.71 |
4.52 |
echocardiography |
0.0 |
|
0 |
|
|
101807 |
2641 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
43.0 |
% |
2.0 |
4.47 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
|
99365 |
2278 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 6 |
39.0 |
% |
2.2 |
5.39 |
echocardiography |
0.0 |
|
0 |
|
|
99641 |
2319 |